FDA inspection
Novo Nordisk Pharmaceutical Industries LP: FDA inspection ending May 13, 2022
FDA inspection 1170708 · Voluntary Action Indicated (VAI) · Clayton, NC
Key facts
| Inspection ID | 1170708 |
|---|---|
| Firm | Novo Nordisk Pharmaceutical Industries LP |
| FEI number | 1000158576 |
| Address | 3612 Powhatan Rd |
| City | Clayton |
| State | NC |
| ZIP | 27527-9217 |
| Fiscal year | 2022 |
| Inspection end date | May 13, 2022 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | New Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data